e-learning
resources
Vienna 2009
Monday, 14.09.2009
Treatment and prevention of lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Study on mechanism of resistance in
Acinetobacter baumannii
to quinolones
M. Huang, Y. Wang, W. Wang (Nanjing, China)
Source:
Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Session:
Treatment and prevention of lower respiratory tract infections
Session type:
Thematic Poster Session
Number:
2427
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Huang, Y. Wang, W. Wang (Nanjing, China). Study on mechanism of resistance in
Acinetobacter baumannii
to quinolones. Eur Respir J 2009; 34: Suppl. 53, 2427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Detection of mutations associated with isoniazid and rifampicin resistance in
M. tuberculosis
isolates from Kazakhstan
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Treatment of difficult Gram-positive infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=113
Year: 2004
Minimal inhibitory concentrations (MICs) of mefloquine: in vitro activity against MDR- and nonMDR-Tb strains
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
Source: Eur Respir J 2009; 33: 581-585
Year: 2009
Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Characterisation and prevalence of macrolide resistance
Streptococcus pneumoniae
infecting pediatric patients
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
The effect on imipenem on the regulation of
ampC
and
oprD
genes in
Pseudomonas
biofilm
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Aminoglycoside ototoxicity monitoring in multidrug resistant tuberculosis: How much is enough?
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012
The resistome and other mechanisms of antibiotic resistance
Source: International Congress 2015 – Antibiotic resistance in respiratory infections
Year: 2015
Long-term, low-dose azithromycin treatment reduces the prevalence of
staphylococcus aureus
, but selects for macrolide resistance in Danish CF-patients
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones},
Source: Eur Respir J 2012; 40: 814-822
Year: 2012
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Trends of MBT drug resistance
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
Source: Eur Respir J , 49 (4) 1700173; DOI: 10.1183/13993003.00173-2017
Year: 2017
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
Source: Eur Respir J , 49 (4) 1700317; DOI: 10.1183/13993003.00317-2017
Year: 2017
A multicenter study of antimicrobial resistance of clinical strains of pneumococci in Kyrgyzstan
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Unit of multidrug resistant tuberculosis - effect of treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 614s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept